(1)
Alsieni, M.; Babader, R.; Kenany, S.; Abdulgader, S.; Alafif, R.; Alahmadi, A.; Aloufi, A.; Fallatah, E.; AlQahtani, R.; Izaldin, A. The Prevalence Regarding the Use of Glucagon-Like Peptide-1 (GLP-1) Agonists As an Obesity Treatment Among Adult Patients at King Abdulaziz University Medical Services Center, Jeddah, Saudi Arabia: A Descriptive Cross-Sectional Study: The Prevalence of Glucagon-Like Peptide-1 (GLP-1) Agonists Use As an Obesity Treatment Among Adults in Saudi Arabia. JKAU Med Sci 2024, 31.